NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the "Company"), announced that Nanoviricides CEO Dr Anil ...
Experiments suggests H9N2 has adapted to human cells, but cases of person-to-person transmission haven’t been reported yet ...
China's GDIIST research institute has announced the development and soon release of the BIE-1, an AI supercomputer inspired ...
Scientists found a virus-like living entity in human bodies named "obelisks" - small loops of RNA, each a thousand genetic ...
NanoViricides, Inc. (NYSE American: NNVC ) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus cannot escape, announced that it will be ...
Experiments suggests H9N2 has adapted to human cells but cases of person-to-person transmission haven’t been reported yet.
Ebola is one of the nasty viruses that can hide in the body even after a patient recovers and tests negative. It can reemerge ...
Ebola is one of the nasty viruses that can hide in the body even after a patient recovers and tests negative. It can reemerge ...
Ebola is one of the nasty viruses that can hide in the body even after a patient recovers and tests negative. It can reemerge and trigger a new outbreak years later. How do they survive? And how can ...
Island Pharma aims to turn Galidesivir, its antiviral ace against Marburg, into reality – with the FDA’s November call to ...
SHELTON, CONNECTICUT / ACCESS Newswire / October 15, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), reports that an analyst research report was published on the Company that explains ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results